Literatur
- 1
Belfort M A, Anthony J, Saade G R, Allen J.
A comparison of magnesium sulfate and nimodipine for the prevention of eclampsia.
N Engl J Med.
2003;
348
304-311
- 2
Bertel O, Conen D, Radu E W, Müller J, Lang C, Dubach U C.
Nifedipine in hypertensive emergencies.
BMJ.
1983;
286
19-21
- 3
Bertel O, Marx E.
Hypertensive emergencies.
Nephron.
1987;
47
(Suppl)
51-56
- 4
Brakemeier S, Eichler I, Hoyer J.
Hypertensive Notfälle.
Dtsch Med Wochenschr.
2002;
127
2392-2395
- 5
Brown M J, Palmer C R, Castaigne A. et al .
Morbidity and mortality in patients randomised to double - blind treatment with a
long - acting calcium - channel blocker or diuretic in the International Nifedipine
GITS study: Intervention as a Goal in Hypertension Treatment (INSIGHT).
Lancet.
2000;
356
366-372
- 6
Calkoun D A, Oparil S.
Treatment of hypertensive crisis.
N Engl J Med.
1990;
323
1177
- 7
Cotter G, Metzger E, Kaluski E. et al .
Randomised trial of high - dose isosorbide dinitrate plus low - dose furosemide versus
high - dose furosemide plus low - dose isosorbide dinitrate in severe pulmonary
oedema.
Lancet.
1998;
351
389-393
- 8
Cunningham F G, Marshall D, Lindheimer M D.
Hypertension in pregnancy.
N Engl J Med.
1992;
326
927-932
- 9
Deutsche Liga zur Bekämpfung des hohen Blutdruckes .
Leitlinien für die Prävention, Erkennung, Diagnostik und Therapie der arteriellen
Hypertonie.
Dtsch Med Wochenschr.
2001;
126
201-238
- 10
European Society of Hypertension .
European Society of Cardiology guidelines fort he management of arterial hypertension.
Journal of Hypertension.
2003;
21
1011-1053
- 11
Flaherty J T.
Comparison of intravenous nitroglycerin and sodium nitroprusside in acute myocardial
infarction.
Am J Med.
1983;
74
53-60
- 12 Frishman W. Management of hypertensive urgencies and emergencies. New York: McGraw-Hill
In: Frishman WH, Sonnenblick EH, eds. Cardiovascular pharmacotherapeutics 1997:
1577-1589
- 13
Gandhi S K, Powers J C, Nomeir A M. et al .
The pathogenesis of acute pulmonary edema associated with hypertension.
N Engl J Med.
2001;
344
17-22
- 14
Graham D I.
Ischemic brain damage following emergency blood pressure lowering in hypertensive
patients.
Acta Med Scan.
1983;
678
61-69
(Suppl)
- 15
Greene C S, Gretler D D, Cervenka K.
Cerebral blood flow during the acute therapy of severe hypertension with oral clonidine.
Am J Emerg Med.
1990;
8
293-296
- 16
Gudbrandsson T.
Malignant hypertension: a clinical follow - up study with special reference to renal
and cardiovascular function and immunogenetic factors.
Acta Med Scand.
1981;
650
(Suppl)
1-62
- 17
He J, Whelton P K.
Epidemiology and prevention of hypertension.
Med Clin N Am.
1997;
81
1077-1097
- 18
Joint - National Committee .
The sixth report of the Joint National Committee on prevention, detection, evaluation,
and treatment of high blood pressure.
Arch Int Med.
1997;
157
2413-2446
- 19 Kaplan N M. Hypertensive crisis. 6th edn Baltimore:Williams and Willkens In: Kaplan
NM, ed. Clinical hypertension 1994 344: 135-138
- 20
Kaplan N M.
Management of hypertensive emergencies.
Lancet.
1994;
344
1335-1338
- 21 Kindermann W, Rast R. Hypertonie, Bewegung, Sport. Aktuelles Wissen Hoechst,. Reihe
Herz- Kreislauf, München 1991
- 22
Kitiyakara C, Guzman N J.
Malignant hypertension and hypertensive emergencies.
J Am Soc Nephrol.
1998;
9
133-142
- 23
Ledingham J GG, Rajagopalan B.
Cerebral complications in the treatment of accelerated hypertension.
Q J Med.
1979;
48
25-41
- 24
Lip G YH, Beevers G, Beevers M.
The failure of malignant hypertension zu decline: a survey of 24 yearŽs experience
in a multiracial population in England.
J Hypertens1994;.
12
1297-1305
- 25
Mullan S.
Conservative management of the recently ruptured aneurysm.
Surg Neurol.
1975;
3
27-32
- 26
Neaton J D, Wentworth D. For the Multiple Risk Factor Intervention Trial Research
Group .
Serum cholesterol, blood pressure, cigarette smoking, and death from coronary heart
disease: overall findings and differences by age for 316.099 white men.
Arch Intern Med.
1992;
152
56-60
- 27
Nightingale S L.
New labeling for sodium nitroprussid emphasizes risk of cyanide toxicity.
JAMA.
1991;
265
847
- 28
Pahor M, Psaty B M, Alderman M H. et al .
Health outcomes associated with calcium antagonists compared with other first - line
antihypertensive therapies: a meta - analysis of randomised controlled trials.
Lancet.
2000;
356
1949-1954
- 29
Ram C VS.
Immediate management of severe hypertension.
Hypertension.
1995;
13
579-591
- 30 Scholze J. Hypertonie kompakt. Blackwell Wissenschafts - Verlag Berlin-Wien 2002
- 31
Stamler J, Stamler R, Neaton J D.
Blood pressure, systolic and diastolic, and cardiovascular risks. US population data.
Arch Intern Med.
1993;
153
598-615
- 32
Strandgaard S, Paulson O B.
Cerebral blood flow and its pathophysiology in hypertension.
Am J Hypertens.
1989;
2
486-492
- 33
Sunder-Plassmann G, Kittler H, Eberle C. et al .
Angiotensin converting enzyme DD genotype is associated with hypertensive crisis.
Crit Care Med.
2002;
30
2236-2241
- 34
Sundgren P C, Edvardsson B, Holtas S.
Serial investigation of perfusion disturbances and vasogenic oedema in hypertensive
encephalopathy by diffusion and perfusion weighted imaging.
Neurorad.
2002;
44
299-304
- 35
Suwelack B, Gerhardt U, Hohage H.
Therapy of hypertensive crises.
Med Klin.
2000;
95
286-292
- 36
Tepel M, Zidek W.
Hypertensive crisis: pathophysiology, treatment and handling of complications.
Kidney Int.
1998;
53
2-5
- 37
Varon J, Marik P E.
The diagnosis and management of hypertensive crises.
Chest.
2000;
118
214-227
- 38
Vaughan C J, Delanty N.
Hypertensive emergencies.
Lancet.
2000;
29
411-417
- 39
Wenzel U O, Stahl R A, Grieshaber M, Schwietzer G.
Diagnostic and therapeutic procedures by doctors for patients in a hypertensive crisis
(An inquiry in 56 internal medicine clinics).
Dtsch Med Wochenschr.
1998;
123
443-447
- 40
Yagil Y, Kobrin I, Leibel B.
Ischemic ECG change with initial nifedipine therapy of severe hypertension.
Am Heart J.
1982;
103
49-50
Prof. Dr. Michael Böhm
Medizinische Klinik und Poliklinik - Innere Medizin III, Universität des Saarlandes
66421 Homburg/Saar
Phone: 06841/1623372
Fax: 06841/1623369
Email: boehm@med-in.uni-sb.de
